survival minimum of 1 year [clinicaltrials_resource:8dabc866a9460738246acffd63e351a1]

survival minimum of 1 year [clinicaltrials_resource:8dabc866a9460738246acffd63e351a1]

infusion of autologous CD34+ cells transduced with retroviral vector encoding ADA after non-myeloablative conditioning with Busulphan
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]
http://bio2rdf.org/clinicaltrials_resource:8dabc866a9460738246acffd63e351a1
ADA Gene Transfer Into Hematopoietic Stem/Progenitor Cells for the Treatment of ADA-SCID [clinicaltrials:NCT00598481]
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]

survival minimum of 1 year [clinicaltrials_resource:8dabc866a9460738246acffd63e351a1]

infusion of autologous CD34+ cells transduced with retroviral vector encoding ADA after non-myeloablative conditioning with Busulphan
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]
http://bio2rdf.org/clinicaltrials_resource:8dabc866a9460738246acffd63e351a1
Bio2RDF identifier
8dabc866a9460738246acffd63e351a1
Bio2RDF namespace
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:8dabc866a9460738246acffd63e351a1
measure [clinicaltrials_vocabulary:measure]
time frame [clinicaltrials_vocabulary:time-frame]
description
infusion of autologous CD34+ c ...... ve conditioning with Busulphan
identifier
clinicaltrials_resource:8dabc866a9460738246acffd63e351a1
title
survival minimum of 1 year
@en
inDataset
type
label
survival minimum of 1 year [clinicaltrials_resource:8dabc866a9460738246acffd63e351a1]
@en